Track Spencer Pharmaceutical's operating income ($1.3M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Mar 31, 2004
Trailing 12 months ending Mar 31, 2004
As of the most recent data (March 2004), SPPH shows a operating income of $1.3M. That compares with $730K in the prior-year period — up 81.9% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SPPH's operating income is now $1.3M (was $730K) — a 81.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Spencer Pharmaceutical is outperforming or lagging.
Tracking SPPH's operating income over time shows whether Spencer Pharmaceutical is scaling, shrinking, or reshaping that part of the business. The current reading is $1.3M That compares with $730K in the prior-year period — up 81.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this operating income page, Stockcircle has Spencer Pharmaceutical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $1.3M) with ownership activity and broader fundamentals.